Miller Joseph M, Maupin Robert T, Mestad Renee E, Nsuami Malanda
Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Sex Transm Dis. 2003 Sep;30(9):728-30. doi: 10.1097/01.OLQ.0000075851.75140.25.
Late pregnancy rescreening is advised for at-risk patients, but data supporting this recommendation are lacking. The intent of this study was to determine the value of a late-pregnancy test for gonorrhea after a negative initial test at the beginning of prenatal care.
A retrospective chart review of clinic records over a 29-month period identified patients with a positive DNA direct assay for gonorrhea either initially or at 34 weeks.
Of 751 women, 38 (5.1%) had gonorrhea diagnosed at their first testing; 19 women (2.5%) were positive only at their second screening. For one patient, both tests were positive.
Repeating screening for gonorrhea at 34 weeks in a high-prevalence population is warranted.
建议对高危患者进行孕晚期重新筛查，但缺乏支持这一建议的数据。本研究的目的是确定在产前检查开始时初次检测为阴性的情况下，孕晚期淋病检测的价值。
对29个月期间的临床记录进行回顾性图表审查，确定初次或在34周时淋病DNA直接检测呈阳性的患者。
在751名女性中，38名（5.1%）在首次检测时被诊断为淋病；19名女性（2.5%）仅在第二次筛查时呈阳性。有一名患者两次检测均为阳性。
在高流行人群中，有必要在34周时重复进行淋病筛查。
